[1] Sun X, Wu X, Duan Y, et al. Family-Based Association Study of rs17300539 and rs12495941 Polymorphism in Adiponectin Gene and Polycystic Ovary Syndrome in a Chinese Population[J].Med Sci Monit,2017,6(23):78-84.
[2] 秦静波,王济.多囊卵巢综合征中医体质类型及辨体论治思路[J].中医杂志,2016,57(18):1553-1556.
[3] Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J].Hum Reprod,2004,81(1):19-25.
[4] Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline[J]. Journal of Clinical Endocrinology & Metabolism, 2013, 98(12):4565-4592.
[5] 郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.
[6] 张玉珍.中医妇科学[M].北京:中国中医药出版社,2007:128-130.
[7] 陈晓红,潘玉红.多囊卵巢综合征发病机制的研究进展[J].医学综述, 2012,18(20):3444-3447.
[8] Zhang XJ, Huang LL, Su HX, et al.Characterizing plasma phospholipid fatty acid profiles of polycystic ovary syndrome patients with and without insulin resistance using GC-MS and chemometrics approach[J].J Pharmaceutical Biomedical Analysis, 2014,95(3):85-92.
[9] Weintraub A, Margalioth EJ, Chetrit AB, et al.The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRHantagonist short protocol in polycystic ovary syndrome and low responders[J].Eur J Obstet Gynecol Reprod Biol,2014,176(1):163-167.
[10] 谢幸,苟文丽,林仲秋,等.妇产科学[M].北京:人民卫生出版社,2014: 369.
[11] 冉爱东.炔雌醇环丙孕酮片、二甲双胍缓释片联合克罗米芬治疗多囊卵巢综合征不孕患者的临床疗效[J].中国妇幼保健,2011,26(22): 3443-3445.
[12] 王爽,陈蓉.多囊卵巢综合征中医研究进展[J].中医临床研究,2016,8(8):144-147.
[13] 方庆霞,邹萍,李坤寅.补肾促排方治疗多囊卵巢综合征排卵障碍性不孕56例临床研究[J].中医杂志,2016,57(11):942-945.
[14] 高金金,侯丽辉,李妍.应用补肾化痰法治疗多囊卵巢综合征的研究进展[J].中医药信息,2016,33(2):112-114.
[15] 杨莉.补肾活血清肝方联合克罗米芬对多囊卵巢综合征患者激素水平的影响[J].中国实用医刊,2016,43(9):54-55.
[16] 罗茜. 达英-35治疗多囊卵巢综合症的临床疗效分析[J]. 临床医药实践, 2010,(10):591-593.
[17] 赵薇. 78例达英-35治疗多囊卵巢综合征不孕的临床疗效观察[J]. 中国妇幼保健, 2012, 27(16):2485-2487.
[18] 刘丽娟.桑寄生现代临床应用研究进展[J].检验医学与临床,2009,6(12):1001-1002.
[19] 汪文来,鞠大宏,刘梅洁,等.续断有效成分药理学研究进展[J].中国医药导刊,2015,(10):1059-1060.
[20] 张明发,沈雅琴.薏苡仁抗代谢综合征的药理作用研究进展[J].药物评价研究,2014,37(2):178-183.
[21] 徐硕,姜文清,邝咏梅,等.茯苓的化学成分及生物活性研究进展[J].西北药学杂志,2016,31(3):327-330.
[22] 张尚智,朱田田,晋玲,等.当归单体成分与复合制剂功效研究进展[J].中国中医药信息杂志,2016,23(12):128-132.
[23] 张静,彭海燕.泽兰药理作用研究进展[J].河北中医,2015,37(3):460-463.
[1]苏恒香 刘雁峰 赵岑等.多囊卵巢综合征在女性各生理阶段病机特点概述[J].环球中医药,2014,7(01):63.
SU Heng xiang,LIU Yan feng,ZHAO Ceng,et al.Overview on the pathomechanism features of PCOS in each physiological stage in females[J].,2014,7(06):63.
[2]张永兴 李静云.温肾祛痰调周法与西药结合治疗多囊卵巢综合征45例[J].环球中医药,2014,7(03):222.
[3]刘新敏,刘睿,艾莉,等.基于血清异常激素的多囊卵巢综合征中医证候研究[J].环球中医药,2013,6(01):12.
LIU Xin min,LIU Rui,AI li,et al.Research of polycystic ovarian syndrome TCM syndromes based on serum abnormal hormones[J].,2013,6(06):12.
[4]胡敏,张跃辉,侯丽辉,等.多囊卵巢综合征“冲任停滞”的内涵探讨[J].环球中医药,2013,6(02):111.
[5]刘新敏,赵一鸣.降胃气在治疗多囊卵巢综合征中的作用[J].环球中医药,2014,7(05):357.
[6]马兰,刘新敏.多囊卵巢综合征高雄激素血症的中医药治疗进展[J].环球中医药,2012,5(08):633.
MA Lan,LIU Xin-min..Progress on treatment of PCOS with hyperandrogenism with traditional Chinese medicine[J].,2012,5(06):633.
[7]王秀霞,宋玉林.中药治疗多囊卵巢综合征所致不孕的研究进展[J].环球中医药,2012,5(10):797.
MWANG Xiu xia,SONG Yu lin..Research progress of treatment of infertility resulted from PCOS with TC[J].,2012,5(06):797.
[8]朱秀芬 王惠琴.近5 年多囊卵巢综合征临床研究进展[J].环球中医药,2014,7(06):497.
ZHU Xiu fen,WANG Hui qin..Progress of polycystic ovary syndrome in the past five years of clinical studies: a clinical research[J].,2014,7(06):497.
[9]辛喜艳 李东 郭佳 刘承 姬晓兰.多囊卵巢综合征中医证候特征及中医药治疗思路评述[J].环球中医药,2015,8(06):679.[doi: A doi:10.3969/j.issn.1674-1749.2015.06.010]
XIN Xi-yan,LI Dong,GUO Jia,et al.A brief summary of TCM syndromes characteristics and treatment ideas on polycystic ovary syndrome[J].,2015,8(06):679.[doi: A doi:10.3969/j.issn.1674-1749.2015.06.010]
[10]史梅莹,赵燕,王天芳.多囊卵巢综合征375例病性类证候要素分布
特点[J].环球中医药,2015,8(05):571.[doi:10.3969/j.issn.16741749.2015.05.015]